Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation.

In this study we assessed whether low density lipoproteins (LDL) isolated from minced aortic atherosclerotic plaques obtained at autopsy (A-LDL) shared structural and functional properties with LDL oxidized by incubation with Cu2+ for 8-18 hours at 20 degrees C (Ox-LDL). Although both A-LDL and Ox-LDL represented monomeric particles about the size of LDL, both differed from LDL in that they showed an increase in electrophoretic mobility relative to LDL, an increase in cholesterol to protein ratio, and an increase in reactivity with a monoclonal antibody that recognizes epitopes on malondialdehyde (MDA)-modified proteins. In addition, both showed an increase in fluorescence at 360 nm excitation, 430 nm emission, an increase in fragmentation of apolipoprotein B with patterns that were quite similar, and an increase in recognition by the scavenger receptor on mouse peritoneal macrophages (MPMs) based on competition of 125I-A-LDL and 125I-Ox-LDL degradation by excess acetylated LDL. In addition, inhibition of degradation by MPMs of 125I-A-LDL and 125I-Ox-LDL by excess unlabeled Ox-LDL and A-LDL were similar. When MDA was added in increasing amounts to labeled LDL and A-LDL, less MDA was required to modify A-LDL than LDl to obtain ligands that were degraded by MPMs to the same degree. Finally, both A-LDL and Ox-LDL but not LDL underwent aggregation (increased metastability) when concentrated to levels exceeding 1 mg protein/ml and showed enhanced macrophage uptake via phagocytosis (inhibition by cytochalasin D). These results demonstrate that A-LDL and Ox-LDL share properties additional to those previously reported, suggesting that oxidation may be a major mode of modification of LDL accumulating in atherosclerotic lesions. This could lead to lipid loading of macrophages induced by phagocytosis of aggregated particles, in addition to unregulated uptake via the scavenger receptor of monomeric particles.

[1]  U. Steinbrecher,et al.  Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. , 1987, The Journal of biological chemistry.

[2]  B. Sobel,et al.  Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. , 1988, Arteriosclerosis.

[3]  J. Cooper,et al.  Effects of cytochalasin and phalloidin on actin , 1987, The Journal of cell biology.

[4]  A. Gotto,et al.  Detergent extraction of tightly-bound apoB from extracts of normal aortic intima and plaques. , 1978, Experimental and molecular pathology.

[5]  B. Clevidence,et al.  Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas. , 1984, Arteriosclerosis.

[6]  D. Steinberg,et al.  Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.

[7]  J. Gaubatz,et al.  Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta. , 1982, Atherosclerosis.

[8]  W. A. Bradley,et al.  Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. , 1979, Biochimica et biophysica acta.

[9]  R. Gerrity.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[10]  A. Gotto,et al.  Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[11]  V. Tertov,et al.  Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. , 1989, Biochemical and biophysical research communications.

[12]  M. Haberland,et al.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.

[13]  O. Quehenberger,et al.  Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. , 1989, Arteriosclerosis.

[14]  A. Gotto,et al.  Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studies. , 1973, Biochimica et biophysica acta.

[15]  H. Hoff,et al.  Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. , 1988, Atherosclerosis.

[16]  A. Gown,et al.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. , 1989, The American journal of pathology.

[17]  T. Innerarity,et al.  Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. , 1986, The Journal of biological chemistry.

[18]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[19]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[20]  W. Wagner,et al.  Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. , 1989, Atherosclerosis.

[21]  A. Gotto,et al.  Apo B concentration in the normal human aorta. , 1978, Biochemical and biophysical research communications.

[22]  P. Röschlau,et al.  Enzymatische Bestimmung des Gesamt-Cholesterins im Serum , 1974 .

[23]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[24]  H. Hoff,et al.  Macrophage degradation of LDL extracted from human aortic plaques: effect of isolation conditions. , 1991, Experimental and molecular pathology.

[25]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[26]  D. Steinberg,et al.  A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. , 1989, The Journal of biological chemistry.

[27]  U. Steinbrecher,et al.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. , 1989, The Journal of biological chemistry.

[28]  S. Ylä-Herttuala,et al.  Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.

[29]  H. Esterbauer,et al.  Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. , 1986, Biochimica et biophysica acta.

[30]  F. Hatch.  Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[31]  J L Witztum,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[32]  Gerrity Rg.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[33]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[34]  A. Fogelman,et al.  Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. , 1989, Journal of lipid research.

[35]  D. Steinberg,et al.  Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism , 1987, Arteriosclerosis.

[36]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[37]  B. Lewis,et al.  Modified plasma-derived lipoproteins in human atherosclerotic plaques. , 1988, Atherosclerosis.

[38]  S. Parthasarathy,et al.  Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. , 1987, Journal of lipid research.

[39]  T. Nikkari,et al.  Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. , 1988, Journal of lipid research.

[40]  S. Narumiya,et al.  Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein. , 1988, The Journal of clinical investigation.

[41]  J. Gaubatz,et al.  Ultrastructural localization of apolipoprotein B in human aortic and coronary atherosclerotic plaques. , 1977, Experimental and molecular pathology.

[42]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[44]  D. Steinberg,et al.  Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. , 1990, Journal of lipid research.

[45]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[46]  P. Edwards,et al.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[47]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[48]  O. Quehenberger,et al.  Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. , 1987, Journal of lipid research.

[49]  A. Habeeb,et al.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.

[50]  E. B. Smith,et al.  Relationship between low-density lipoprotein in aortic intima and serum-lipid levels. , 1972, Lancet.

[51]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H F Hoff,et al.  A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. , 1986, Journal of lipid research.

[53]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[54]  H. Mcgill.  Fatty streaks in the coronary arteries and aorta. , 1968, Laboratory investigation; a journal of technical methods and pathology.